Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort studyObservational Study Published on 2022-09-012022-10-05 Journal: Respiratory Research [Category] [DOI] 10.1186/s12931-022-02155-x PMC 바로가기 [Article Type] Observational Study
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana projectArticle Published on 2022-08-292022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.966416 PMC 바로가기
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders중증급성호흡기증후군 코로나바이러스 2로 이전에 감염된 의료진과 응급구조원 중 재감염Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciab952 PMC 바로가기 [Article Type] Article
Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2CoronaVac 및 BNT162b2를 사용한 이종 프라임-부스트 백신 접종의 체액 면역 반응 특성화Article Published on 2022-08-192022-09-12 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.07.023 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial건강한 성인을 대상으로 한 단일 용량 V590(rVSV-SARS-CoV-2 Vaccine)의 근육 내 안전성 및 면역원성: 1상 무작위 배정, 이중 맹검, 위약 대조, 용량 범위 시험 결과Clinical Trial Published on 2022-08-012022-09-11 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2022.104138 PMC 바로가기 [Article Type] Clinical Trial
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical TrialSARS-CoV-2 감염 외래 환자에서 Casirivimab과 Imdevimab COVID-19 항체 조합의 바이러스학적 효능: 2상 용량 범위 무작위 임상 시험Clinical Trial Published on 2022-08-012022-09-12 Journal: JAMA Network Open [Category] [DOI] 10.1001/jamanetworkopen.2022.25411 PMC 바로가기 [Article Type] Clinical Trial
Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients혈청 음성 암 환자에서 BNT162b2 COVID-19 백신의 3차 추가 접종에 대한 혈청학적 반응Article Published on 2022-08-012022-09-11 Journal: Cancer Reports [Category] [DOI] 10.1002/cnr2.1645 PMC 바로가기 [Article Type] Article
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis다발성 경화증이 있는 혈청 음성인의 COVID-19 추가 백신 접종에 대한 반응Article Published on 2022-08-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] [DOI] 10.1016/j.msard.2022.103937 PMC 바로가기 [Article Type] Article
Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study중증 호흡부전 환자에서 코로나19 이전 및 코로나19 이후 회복기 혈장 수혈에 대한 SARS-CoV-2 항체 반응의 동역학: 관찰 사례-대조군 연구Observational Study Published on 2022-08-012022-09-12 Journal: Journal of Clinical Pathology [Category] [DOI] 10.1136/jclinpath-2020-207356 PMC 바로가기 [Article Type] Observational Study
Specific CD4+ T Cell Responses to Ancestral SARS-CoV-2 in Children Increase With Age and Show Cross-Reactivity to Beta Variant어린이의 조상 SARS-CoV-2에 대한 특정 CD4+ T 세포 반응은 나이가 들어감에 따라 증가하고 베타 변이체에 대한 교차 반응성을 나타냅니다Article Published on 2022-07-152022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.867577 PMC 바로가기 [Article Type] Article